**Core Concept**
Neostigmine is an anticholinesterase inhibitor that enhances cholinergic transmission by preventing the breakdown of acetylcholine (ACh) at the neuromuscular junction. Non-depolarizing neuromuscular blockers work by competitively inhibiting the action of acetylcholine at the nicotinic receptors, leading to muscle paralysis.

**Why the Correct Answer is Right**
Option A is incorrect because neostigmine does not decrease the breakdown of acetylcholine at the motor end plate. Instead, it inhibits the enzyme acetylcholinesterase, which is responsible for breaking down ACh. This action increases the concentration and duration of action of ACh at the neuromuscular junction.

**Why Each Wrong Option is Incorrect**
**Option B:** Preventing K+ efflux is not a mechanism of neostigmine in antagonizing non-depolarizing blockade. Non-depolarizing blockers work by blocking the nicotinic receptors, while neostigmine works by increasing the concentration of ACh.
**Option C:** Increasing the release of acetylcholine at the motor end plate is not a direct action of neostigmine. Neostigmine works by inhibiting acetylcholinesterase, which increases the concentration of ACh available for release.
**Option D:** Depolarization at the motor end plate is a mechanism of action of succinylcholine, not neostigmine. Neostigmine works by increasing the concentration of ACh, not by directly depolarizing the muscle.

**Clinical Pearl / High-Yield Fact**
It's essential to remember that neostigmine is used to reverse non-depolarizing neuromuscular blockade, but it does not work in cases of depolarizing blockade, such as succinylcholine-induced paralysis.

**Correct Answer:**
✓ Correct Answer: A. Decreasing the breakdown of acetyl choline at the motor end plate